Roche Pays $220 Million For Blood Testing Innovator

Law360, New York (July 02, 2013, 4:40 PM ET) -- Swiss pharmaceutical titan Roche Holding AG announced Tuesday that it will shell out $220 million to acquire Constitution Medical Investors Inc., which is developing a new testing system for blood diseases.

Roche said that more payments could follow if certain incentives are met, but did not provide any details. It made the purchase in an effort to bolster its competitive position in the laboratory hematology testing business.

“With this acquisition, we will further strengthen our commitment to hematology and drive toward integrated laboratory solutions with innovative products...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers